Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity

Inflammatory Bowel Diseases

Volumn 16, Issue 3, 2010, Pages 390-400

  Schmidt, Esben Gjerløff Wedebye ^a   Claesson, Mogens Helweg ^a   Jensen, Simon Skjøde ^b   Ravn, Peter ^b   Kristensen, Nanna Ny ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BIONEER A S   (Denmark)

Author keywords

Colitis; Inflammation; Probiotics; Regulatory T cells

Indexed keywords

BI 504; BI 98; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; CD4+ CD25+ T LYMPHOCYTE; CELL CONTACT; CELL ISOLATION; CELL PROLIFERATION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOSTIMULATION; LACTIC ACID BACTERIUM; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; BIFIDOBACTERIUM; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; FECES; FEMALE; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LACTIC ACID; LACTOBACILLUS ACIDOPHILUS; MICE; MICE, INBRED BALB C; PROBIOTICS; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 77149172913     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21068     Document Type: Article

References (57)

1. Cummings JH. Dietary carbohydrates and the colonic microflora. Curr Opin Clin Nutr Metab Care. 1998;1:409-414.
2. Isolauri E. Probiotics and gut inflammation. Curr Opin Gastroenterol. 1999;15:534-537.
3. Haller DC, Bode C, Hammes WP, et al. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut. 2000;47:79-87.
4. Morita H, He F, Fuse T, et al. Adhesion of lactic acid bacteria to caco-2 cells and their effect on cytokine secretion. Microbiol Immunol. 2002;46:293-297.
5. Maassen CB, van Holten-Neelen C, Balk F, et al. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine. 2000;18:2613-2623.
6. Madsen KL, Doyle JS, Jewell LD, et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 1999;116:1107-1114.
7. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992;32:141-144.
8. Sheih YH, Chiang BL, Wang LH, et al. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr. 2001;20:149-156.
9. Gill HS, Rutherfurd KJ, Cross ML. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol. 2001;21: 264-271.
10. Petrof EO, Kojima K, Ropeleski MJ, et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology. 2004;127: 1474-1487.
11. Tien MT, Girardin SE, Regnault B, et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol. 2006;176:1228-1237.
12. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut. 1998;42:2-7.
13. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol. 1994;77:412-420.
14. Moller PL, Paerregaard A, Gad M, et al. Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells. Inflamm Bowel Dis. 2005;11: 814-819.
15. Bergonzelli GE, Blum S, Brussow H, et al. Probiotics as a treatment strategy for gastrointestinal diseases? Digestion. 2005;72:57-68.
16. Heilpern D, Szilagyi A. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics. Rev Recent Clin Trials. 2008;3:167-184.
17. Rioux KP, Fedorak RN. Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol. 2006;40:260-263.
18. Gad M. Regulatory T cells in experimental colitis. Curr Top Microbiol Immunol. 2005;293:179-208.
19. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-1640.
20. Gad M, Pedersen AE, Kristensen NN, et al. Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells. Eur J Immunol. 2004;34:695-704.
21. Powrie F, Correa-Oliveira R, Mauze S, et al. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med. 1994;179:589-600.
22. Gad M, Kristensen NN, Kury E, et al. Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T cell responses in vitro and in vivo. Immunology. 2004;113:499-508.
23. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939-3943.
24. Di GC, Marinaro M, Sanchez M, et al. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol. 2005;174:3237-3246.
25. Foligne B, Zoumpopoulou G, Dewulf J, et al. A key role of dendritic cells in probiotic functionality. PLoS ONE. 2007;2:E313 1-12.
26. Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut. 2004;53: 1602-1609.
27. Lammers KM, Brigidi P, Vitali B, et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol. 2003;38: 165-172.
28. Pronio A, Montesani C, Butteroni C, et al. Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis. 2008;14:662-668.
29. Smits HH, Engering A, van der KD, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol. 2005; 115:1260-1267.
30. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol. 2002;168:171-178.
31. Mohamadzadeh M, Olson S, Kalina WV, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A. 2005;102:2880-2885.
32. Wagner RD, Warner T, Roberts L, et al. Variable biotherapeutic effects of Lactobacillus acidophilus isolates on orogastric and systemic candidiasis in immunodeficient mice. Rev Iberoam Micol. 1998;15:271-276.
33. Tan PS, Chapot-Chartier MP, Pos KM, et al. Localization of peptidases in Lactococci. Appl Environ Microbiol. 1992;58:285-290.
34. Schuster GS, Hayashi JA, Bahn AN. Toxic properties of the cell wall of gram-positive bacteria. J Bacteriol. 1967;93:47-52.
35. Johansen E, Kibenich A. Characterization of Leuconostoc isolates from commercial mixed strain mesophilic starter cultures. J Dairy Sci. 1992;75:1186-1191.
36. O'Sullivan DJ, Klaenhammer TR. Rapid mini-prep isolation of highquality plasmid DNA from Lactococcus and Lactobacillus spp. Appl Environ Microbiol. 1993;59:2730-2733.
37. Kabelitz D, Wesch D, Oberg HH. Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit Rev Immunol. 2006; 26:291-306.
38. Wan S, Xia C, Morel L. IL-6 produced by dendritic cells from lupusprone mice inhibits CD4+CD25+ T cell regulatory functions. J Immunol. 2007;178:271-279.
39. O'Sullivan BJ, Thomas HE, Pai S, et al. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol. 2006;176: 7278-7287.
40. Yang S, Tamai R, Akashi S, et al. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun. 2001;69:2045-2053.
41. Watanabe T, Kitani A, Murray PJ, et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol. 2004;5:800-808.
42. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731-734.
43. Netea MG, Ferwerda G, de Jong DJ, et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol. 2005;174:6518-6523.
44. Tada H, Aiba S, Shibata K, et al. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun. 2005;73:7967-7976.
45. Zeuthen LH, Christensen HR, Frokiaer H. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin Vaccine Immunol. 2006;13:365-375.
46. Matsuguchi T, Takagi A, Matsuzaki T, et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol. 2003;10:259-266.
47. Fujimoto Y, Inamura S, Kawasaki A, et al. Chemical synthesis of peptidoglycan fragments for elucidation of the immunostimulating mechanism. J Endotoxin Res. 2007;13:189-196.
48. Zeuthen LH, Fink LN, Frokiaer H. Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology. 2008;124:489-502.
49. Cambi A, Koopman M, Figdor CG. How C-type lectins detect pathogens. Cell Microbiol. 2005;7:481-488.
50. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869-8872.
51. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A. 2000;97:13766-13771.
52. Takeuchi O, Kawai T, Muhlradt PF, et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol. 2001;13:933-940.
53. Hoebe K, Georgel P, Rutschmann S, et al. CD36 is a sensor of diacylglycerides. Nature. 2005;433:523-527.
54. Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc. 2007;66:307-315.
55. Prescott SL, Bjorksten B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol. 2007;120:255-265.
56. Paineau D, Carcano D, Leyer G, et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol. 2008;53:107-113.
57. Linehan DC, Goedegebuure PS. CD25+ CD4+ regulatory T cells in cancer. Immunol Res. 2005;32:155-168.